Zydus Cadila and Sandoz have received generics approvals in North America. The approvals may include treatments for conditions such as schizophrenia and hiv, although the specific drugs approved are not certain. Other reports suggest that various pharmaceutical companies, including Lupin, are involved in the development and marketing of generic drugs, but the exact relationship to the Zydus Cadila and Sandoz approvals is unclear.